Warburg Pincus Participates in $76.5 Million Series C Equity Funding for Outset Medical
05.08.17
This is only gets display when printing
Simpson Thacher is representing Warburg Pincus in connection with a $76.5 million Series C funding round for Outset Medical. A new investor, funds advised by T. Rowe Price Associates, Inc., led the round, with participation from existing investors including Warburg Pincus.
Outset is a pioneering medical technology company focused on transforming the patient’s care experience as well as finding cost-effective solutions for both patients and providers.
The Simpson Thacher team included Robert Langdon and Mark Myott (M&A); and David Rubinsky and Jeannine McSweeney (ECEB).